고유량 산소 치료기 시장 : 제품 유형별, 최종사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

High Flow Oxygen Therapy Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

US $ 4,995 ￦ 7,229,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,558,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,295,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

고유량 산소 치료기 시장을 철저하게 분석하고 세계의 전망을 상술하고 있습니다. 이 상세 출판물은 시장 역학, 동향, 기회, 과제에 관한 귀중한 인사이트를 제공하고, 구조의 종합적 개요를 제공합니다. 독자적인 데이터와 통계에 기반한 본 조사에서는 2024-2032년 고유량 산소 치료기 시장의 예측 성장 궤도를 예측하고 있습니다.

2024년, 고유량 산소 치료기 시장의 세계 매출은 14억 달러에 달했습니다. 그럼에도 불구하고 시장은 CAGR 2.4%로 감속하며, 2032년 시장 평가액은 약 17억 달러에 달할 것으로 예측됩니다.

주요 인사이트

• 고유량 산소 치료기 시장 규모(2024년) : 14억 달러
• 예측 시장 가치(2032년) : 17억 달러
• 세계 시장 성장률(CAGR 2024-2032년) : 2.4%

고유량 산소 치료기 시장 - 조사 범위 :

고유량 산소 치료기는 급성 또는 만성 호흡 부전 환자에게 고 유량 산소를 공급하여 호흡기 질환 관리에 중요한 역할을 합니다. 이 장비는 공기와 산소의 정확한 혼합물을 높은 유량으로 공급하여 산소화를 개선하고 호흡 작업을 줄이며 환자의 편안함을 향상시킵니다.

시장의 성장은 인구 동향, 기술 발전, 의료 인프라 개발, 호흡기 질환의 유행 등 다양한 요인의 영향을 받습니다. 또한 규제 당국의 노력, 상환 정책 및 환자 선호도가 시장 역학을 형성하고 고유량 산소 치료기의 설계 및 기능에서 기술 혁신을 촉진합니다.

시장 성장의 촉진요인

호흡기 질환 유병률: 만성폐쇄성폐질환(COPD), 폐렴, 급성호흡곤란증후군(ARDS)과 같은 호흡기 질환의 유병률 증가는 호흡 보조 및 증상 관리를 위한 고유량 산소 치료기에 대한 수요를 견인하고 있습니다.

기기 기술 발전: 개선된 산소 공급 시스템, 일체형 가습 챔버, 휴대용 기기 설계 등 고유량 산소 치료기의 기술 발전은 치료 효과, 환자 순응도 및 의료진의 편의성을 향상시킵니다.

인구 고령화: 인구 고령화 및 합병증 유병률 증가와 같은 인구 통계학적 변화는 고령 환자의 복잡한 헬스케어 요구를 충족시키기 위해 고유량 산소 치료기를 포함한 호흡 관리 솔루션에 대한 수요 증가에 기여하고 있습니다.

시장 성장 억제요인

환급 제한: 고유량 산소 치료기 및 관련 소모품에 대한 환급 범위가 제한적이기 때문에 특히 의료 예산 및 환급 정책이 제한된 지역에서는 시장 도입에 걸림돌이 될 수 있습니다.

경쟁으로 인한 가격 압력: 시장 진출기업 간의 치열한 경쟁과 가격에 민감한 의료 환경은 제품 가격과 이윤율에 하방 압력을 가하여 시장 성장과 수익성에 영향을 미칠 수 있습니다.

시장 기회 :

용도 확대: 고농도 산소 요법은 수술 전후 의료, 중환자 치료, 완화 치료 등 기존 호흡기 영역 외에도 광범위하게 적용되어 새로운 시장 기회가 창출되고, 대응 가능한 환자군이 확대될 것으로 예상됩니다.

기술 혁신 : 기기의 성능, 신뢰성, 사용 편의성을 향상시키기 위한 연구개발에 대한 지속적인 투자와 원격 모니터링 및 원격의료 용도을 위한 디지털 헬스 기술의 통합은 시장의 혁신과 차별화를 촉진할 것입니다.

이 보고서에서 다룬 주요 질문

• 세계 고유량 산소 치료기 시장의 성장을 가속하는 주요 요인은 무엇인가?
• 다양한 헬스케어 환경에서 어떤 기기 유형과 용도가 시장 도입을 촉진하고 있는가?
• 기술의 발전은 고유량 산소 치료기 시장 경쟁 구도를 어떻게 바꾸고 있는가?
• 고유량 산소 치료기 시장에 기여하는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 고유량 산소 치료기 시장의 새로운 동향과 미래 전망은?

경쟁사 정보 및 사업 전략:

Philips 헬스케어, ResMed Inc., Fisher &Paykel Healthcare Limited, Vyaire Medical 등 세계 고유량 산소 치료기 시장의 주요 기업은 경쟁 우위를 확보하기 위해 기술 혁신, 제품 차별화 및 전략적 파트너십에 경쟁 우위를 확보하기 위해 노력하고 있습니다. 이들 기업은 연구개발에 투자하여 첨단 고유량 산소 치료기를 개발하고, 제품 포트폴리오를 확장하고, 다양한 의료 환경에 대한 시장 침투를 강화하고 있습니다. 의료 서비스 프로바이더, 유통업체, 규제 당국과의 협력을 통해 시장 접근성을 높이고 기술 도입을 촉진하는 한편, 임상 연구와 근거 기반 진료에 중점을 두어 빠르게 진화하는 호흡기 치료 분야에서 시장 성장을 가속하고 환자 치료 결과를 개선하고 있습니다.

주요 기업 개요

• Teleflex Medical GmBH
• Philips Respironics
• Vapotherm, Inc.
• ResMed
• VYAIRE MEDICAL, INC.
• Fisher & Paykel Corporation Ltd.
• Armstrong Medical
• Flexicare Medical
• Hamilton Medical Inc.
• Intersurgical Inc
• Inspired Medical
• WILAMed GmBH
• Besmed Health Business Corp
• Shenzhen Micomme Medical Technology Development Co., Ltd
• Shenyang RMS Medical Tech Co. Ltd.
• BMC Medical Co., Ltd.
• Draegerwerk AG & Co. KGaA

고유량 산소 치료기 산업 조사 부문 화

고유량 산소 치료기 시장 : 제품별

• 고유량 비강 캐뉼라
• 고유량 산소 마스크
• 호흡 회로
• 가열식 가습기
• 부속품

고유량 산소 치료기 시장 : 용도별

• 폐렴
• 급성호흡부전

고유량 산소 치료기 시장 : 최종사용자별

• 100상 미만 병원
• 100-250상 병원
• 250-500상 병원
• 500상 이상의 병원

고유량 산소 치료기 시장 : 지역별

• 북미
• 라틴아메리카
• 유럽
• 남아시아
• 동아시아
• 오세아니아
• 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 주요 성공요인

• 제품의 채택/사용 상황 분석
• 인스톨 기반 분석
• 질병 역학
• 최근 제품 릴리스
• 제조업체별 주요 프로모션 전략
• 규제 시나리오
• 환불 시나리오

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 용도별
  • 최종사용자별
  • 국가별
• 2024년 시장 시나리오

제7장 세계의 고유량 산소 치료기 시장 - 가격 분석

• 제품별 지역 가격 분석
• 가격의 내역
  • 제조업체 레벨의 가격 설정
  • 유통업체 레벨의 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격결정 전제

제8장 세계의 고유량 산소 치료기 시장의 수량 분석

• 과거 시장 수량 분석(2019-2023년)
• 현재 및 향후 시장 규모 예측(2024-2032년)
  • 전년대비 성장 동향 분석

제9장 세계의 고유량 산소 치료기 시장의 수요 분석

• 과거 시장 가치 분석(2019-2023년)
• 현재 및 향후 시장 가치 예측(2024-2032년)
  • 전년대비 성장 동향 분석
  • 절대액의 기회 분석

제10장 세계의 고유량 산소 치료기 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모와 수량 분석 : 제품별(2019-2023년)
• 현재와 향후 시장 규모와 수량 분석 및 예측 : 제품별(2024-2032년)
  • 고유량코 캐뉼라
  • 고유량 산소 마스크
  • 호흡 회로
  • 가열식 가습기
  • 액세서리
• 제품별 시장의 매력 분석

제11장 세계의 고유량 산소 치료기 시장 분석 : 용도별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 용도별(2019-2023년)
• 현재 및 향후 시장 규모 분석과 예측 : 용도별(2024-2032년)
  • 폐렴
  • 급성호흡부전
• 용도별 시장의 매력 분석

제12장 세계의 고유량 산소 치료기 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 최종사용자별(2019-2023년)
• 현재 및 향후 시장 규모 분석과 예측 : 최종사용자별(2024-2032년)
  • 100상 미만 병원
  • 100-250상 병원
  • 250-500상 병원
  • 500상 이상의 병원
• 최종사용자별 시장의 매력 분석

제13장 세계의 고유량 산소 치료기 시장 분석 : 지역별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 지역별(2019-2023년)
• 현재 및 향후 시장 규모 분석과 예측 : 지역별(2024-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제14장 북미의 고유량 산소 치료기 시장 분석

제15장 라틴아메리카의 고유량 산소 치료기 시장 분석

제16장 유럽의 고유량 산소 치료기 시장 분석

제17장 동아시아의 고유량 산소 치료기 시장 분석

제18장 남아시아의 고유량 산소 치료기 시장 분석

제19장 오세아니아의 고유량 산소 치료기 시장

제20장 중동 및 아프리카의 고유량 산소 치료기 시장 분석

제21장 시장 구조 분석

• 기업 계층별 시장 분석
• 시장 집중
• 주요 기업의 시장 점유율 분석(%)
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Draegerwerk AG &Co. KGaA
  • Teleflex Medical GmBH
  • Philips Respironics
  • Vapotherm, Inc.
  • ResMed
  • VYAIRE MEDICAL, INC.
  • Fisher &Paykel Corporation Ltd.
  • Armstrong Medical
  • Flexicare Medical
  • Hamilton Medical Inc.
  • Intersurgical Inc
  • Inspired Medical
  • WILAMed GmBH
  • Besmed Health Business Corp
  • Shenzhen Micomme Medical Technology Development Co., Ltd
  • Shenyang RMS Medical Tech Co. Ltd.
  • BMC Medical Co., Ltd.

제23장 전제와 두자어

제24장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has conducted a thorough analysis of the High Flow Oxygen Therapy Devices Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the High Flow Oxygen Therapy Devices Market spanning from 2024 to 2032.

In 2024, the global revenue from the high flow oxygen therapy devices market amounted to US$ 1.4 billion. Nevertheless, the market is projected to experience a decline at a Compound Annual Growth Rate (CAGR) of 2.4%, resulting in a market valuation of approximately US$ 1.7 billion by 2032.

Key Insights:

• High Flow Oxygen Therapy Devices Market Size (2024): US$ 1.4 billion
• Projected Market Value (2032): US$ 1.7 billion
• Global Market Growth Rate (CAGR 2024-2032): 2.4%

High Flow Oxygen Therapy Devices Market - Report Scope:

High flow oxygen therapy devices play a crucial role in the management of respiratory conditions, providing high-flow oxygen delivery to patients with acute or chronic respiratory failure. These devices deliver a precise mixture of air and oxygen at high flow rates, facilitating improved oxygenation, reduced work of breathing, and enhanced patient comfort.

Market growth is influenced by various factors, including demographic trends, technological advancements, healthcare infrastructure development, and the prevalence of respiratory disorders. Additionally, regulatory initiatives, reimbursement policies, and patient preferences shape market dynamics and drive innovation in high flow oxygen therapy device design and functionality.

Market Growth Drivers:

Prevalence of Respiratory Disorders: The increasing prevalence of respiratory conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, and acute respiratory distress syndrome (ARDS), drives the demand for high flow oxygen therapy devices for respiratory support and symptom management.

Advancements in Device Technology: Technological advancements in high flow oxygen therapy devices, including improved oxygen delivery systems, integrated humidification chambers, and portable device designs, enhance treatment efficacy, patient compliance, and healthcare provider convenience.

Aging Population: Demographic shifts, including aging populations and a higher prevalence of comorbidities, contribute to the growing demand for respiratory care solutions, including high flow oxygen therapy devices, to address the complex healthcare needs of elderly patients.

Market Restraints:

Reimbursement Limitations: Limited reimbursement coverage for high flow oxygen therapy devices and related consumables may hinder market adoption, particularly in regions with restrictive healthcare budgets and reimbursement policies.

Competitive Pricing Pressures: Intense competition among market players and price-sensitive healthcare environments may exert downward pressure on product pricing and profit margins, impacting market growth and profitability.

Market Opportunities:

Expanding Application Areas: The broader application of high flow oxygen therapy beyond traditional respiratory indications, including perioperative care, critical care, and palliative care, creates new market opportunities and expands the addressable patient population.

Technological Innovation: Continued investment in research and development to enhance device performance, reliability, and user-friendliness, as well as the integration of digital health technologies for remote monitoring and telehealth applications, fosters market innovation and differentiation.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the high flow oxygen therapy devices market globally?
• Which device types and applications are driving market adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the high flow oxygen therapy devices market?
• Who are the key players contributing to the high flow oxygen therapy devices market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global high flow oxygen therapy devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global high flow oxygen therapy devices market, including Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Limited, and Vyaire Medical, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced high flow oxygen therapy devices, expand their product portfolios, and enhance market penetration across diverse healthcare settings. Collaborations with healthcare providers, distributors, and regulatory agencies facilitate market access and promote technology adoption, while emphasis on clinical research and evidence-based practice fosters market growth and enhances patient outcomes in the rapidly evolving field of respiratory care.

Key Companies Profiled

• Teleflex Medical GmBH
• Philips Respironics
• Vapotherm, Inc.
• ResMed
• VYAIRE MEDICAL, INC.
• Fisher & Paykel Corporation Ltd.
• Armstrong Medical
• Flexicare Medical
• Hamilton Medical Inc.
• Intersurgical Inc
• Inspired Medical
• WILAMed GmBH
• Besmed Health Business Corp
• Shenzhen Micomme Medical Technology Development Co., Ltd
• Shenyang RMS Medical Tech Co. Ltd.
• BMC Medical Co., Ltd.
• Draegerwerk AG & Co. KGaA

Segmentation of High Flow Oxygen Therapy Devices Industry Research

High Flow Oxygen Therapy Devices Market by Product:

• High Flow Nasal Cannulas
• High Flow Oxygen Masks
• Breathing Circuits
• Heated Humidifiers
• Accessories

High Flow Oxygen Therapy Devices Market by Application:

• Pneumonia
• Acute Respiratory Failure

High Flow Oxygen Therapy Devices Market by End User:

• Less than 100 Bed Hospitals
• 100-250 Bed Hospitals
• 250-500 Bed Hospitals
• 500 and Above Bed Hospitals

High Flow Oxygen Therapy Devices Market by Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Installed Base Analysis
• 4.3. Disease Epidemiology
• 4.4. Recent Product Launches
• 4.5. Key Promotional Strategies, By Manufacturers
• 4.6. Regulatory Scenario
• 4.7. Reimbursement Scenario

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Respiratory Care Devices Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increasing Prevalence of Respiratory Diseases
  • 5.2.2. Impact of the COVID-19 Pandemic
  • 5.2.3. Advancements in High Flow Oxygen Therapy Devices
  • 5.2.4. Growth of Non-Invasive Respiratory Support Devices
  • 5.2.5. Growing Proliferation of Infectious Diseases
  • 5.2.6. Cost of High Flow Oxygen Therapy Devices
  • 5.2.7. Rising Geriatric Population Globally
  • 5.2.8. Established Product Manufacturers
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Application
  • 6.1.3. By End User
  • 6.1.4. By Country
• 6.2. 2024 Market Scenario

7. Global High Flow Oxygen Therapy Devices Market - Pricing Analysis

• 7.1. Regional Pricing Analysis By Product
• 7.2. Pricing Break-up
  • 7.2.1. Manufacturer Level Pricing
  • 7.2.2. Distributor Level Pricing
• 7.3. Global Average Pricing Analysis Benchmark
• 7.4. Pricing Assumptions

8. Global High Flow Oxygen Therapy Devices Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2032

• 8.1. Historical Market Volume (Units) Analysis, 2019-2023
• 8.2. Current and Future Market Volume (Units) Projections, 2024-2032
  • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global High Flow Oxygen Therapy Devices Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2032
  • 10.3.1. High Flow Nasal Cannulas
  • 10.3.2. High Flow Oxygen Masks
  • 10.3.3. Breathing Circuits
  • 10.3.4. Heated Humidifiers
  • 10.3.5. Accessories
• 10.4. Market Attractiveness Analysis By Product

11. Global High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2032
  • 11.3.1. Pneumonia
  • 11.3.2. Acute Respiratory Failure
• 11.4. Market Attractiveness Analysis By Application

12. Global High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
  • 12.3.1. Less than 100 Beds Hospitals
  • 12.3.2. 100-250 Beds Hospitals
  • 12.3.3. 250-500 Beds Hospitals
  • 12.3.4. 500 Beds and Above Hospitals
• 12.4. Market Attractiveness Analysis By End User

13. Global High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis By Region

14. North America High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Application
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. High Flow Oxygen Therapy Devices Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.1.2.1. By Country
      • 14.8.1.2.2. By Product
      • 14.8.1.2.3. By Application
      • 14.8.1.2.4. By End User
  • 14.8.2. Canada High Flow Oxygen Therapy Devices Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.2.2.1. By Country
      • 14.8.2.2.2. By Product
      • 14.8.2.2.3. By Application
      • 14.8.2.2.4. By End User

15. Latin America High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units)Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
      • 15.3.1.4.1. By Country
      • 15.3.1.4.2. By Product
      • 15.3.1.4.3. By Application
      • 15.3.1.4.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Application
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Mexico High Flow Oxygen Therapy Devices Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Application
      • 15.8.1.2.3. By End User
  • 15.8.2. Brazil High Flow Oxygen Therapy Devices Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.2.2.1. By Country
      • 15.8.2.2.2. By Product
      • 15.8.2.2.3. By Application
      • 15.8.2.2.4. By End User
  • 15.8.3. Argentina High Flow Oxygen Therapy Devices Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Application
      • 15.8.3.2.3. By End User

16. Europe High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units)Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Nordic Countries & Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Application
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Application
      • 16.8.1.2.3. By End User
  • 16.8.2. Italy High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Application
      • 16.8.2.2.3. By End User
  • 16.8.3. France High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Application
      • 16.8.3.2.3. By End User
  • 16.8.4. U.K. High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Application
      • 16.8.4.2.3. By End User
  • 16.8.5. Spain High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Application
      • 16.8.5.2.3. By End User
  • 16.8.6. BENELUX High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Application
      • 16.8.6.2.3. By End User
  • 16.8.7. Nordic Countries & Russia High Flow Oxygen Therapy Devices Market Analysis
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Application
      • 16.8.7.2.3. By End User

17. East Asia High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units)Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. China High Flow Oxygen Therapy Devices Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Application
      • 17.8.1.2.3. By End User
  • 17.8.2. Japan High Flow Oxygen Therapy Devices Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Application
      • 17.8.2.2.3. By End User
  • 17.8.3. South Korea High Flow Oxygen Therapy Devices Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Application
      • 17.8.3.2.3. By End User

18. South Asia High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units)Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Indonesia
    • 18.3.1.3. Malaysia
    • 18.3.1.4. Thailand
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. India High Flow Oxygen Therapy Devices Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Application
      • 18.8.1.2.3. By End User
  • 18.8.2. Indonesia High Flow Oxygen Therapy Devices Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Application
      • 18.8.2.2.3. By End User
  • 18.8.3. Malaysia High Flow Oxygen Therapy Devices Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Application
      • 18.8.3.2.3. By End User
  • 18.8.4. Thailand High Flow Oxygen Therapy Devices Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Application
      • 18.8.4.2.3. By End User

19. Oceania High Flow Oxygen Therapy Devices Market 2019-2023 and Forecast 2024-2032

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units)Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis & Forecast By Market Taxonomy, 2024-2032
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Application
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Application
  • 19.4.4. By End User
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Country Level Analysis & Forecast
  • 19.7.1. Australia High Flow Oxygen Therapy Devices Market Analysis
    • 19.7.1.1. Introduction
    • 19.7.1.2. Market Analysis and Forecast By Market Taxonomy
      • 19.7.1.2.1. By Product
      • 19.7.1.2.2. By Application
      • 19.7.1.2.3. By End User
  • 19.7.2. New Zealand High Flow Oxygen Therapy Devices Market Analysis
    • 19.7.2.1. Introduction
    • 19.7.2.2. Market Analysis and Forecast By Market Taxonomy
      • 19.7.2.2.1. By Product
      • 19.7.2.2.2. By Application
      • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) High Flow Oxygen Therapy Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2024-2032
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. South Africa
    • 20.3.1.4. North Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Application
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Application
  • 20.4.4. By End User
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries High Flow Oxygen Therapy Devices Market Analysis
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Application
      • 20.8.1.2.3. By End User
  • 20.8.2. Turkey High Flow Oxygen Therapy Devices Market Analysis
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Application
      • 20.8.2.2.3. By End User
  • 20.8.3. South Africa High Flow Oxygen Therapy Devices Market Analysis
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Application
      • 20.8.3.2.3. By End User
  • 20.8.4. North Africa High Flow Oxygen Therapy Devices Market Analysis
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By Application
      • 20.8.4.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis By Tier of Companies
• 21.2. Market Concentration
• 21.3. Market Share Analysis (%) of Top Players
• 21.4. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Draegerwerk AG & Co. KGaA
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Strategic Overview
  • 22.3.2. Teleflex Medical GmBH
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Strategic Overview
  • 22.3.3. Philips Respironics
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Strategic Overview
  • 22.3.4. Vapotherm, Inc.
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Strategic Overview
  • 22.3.5. ResMed
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Strategic Overview
  • 22.3.6. VYAIRE MEDICAL, INC.
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Strategic Overview
  • 22.3.7. Fisher & Paykel Corporation Ltd.
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Key Financials
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Strategic Overview
  • 22.3.8. Armstrong Medical
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Key Financials
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Strategic Overview
  • 22.3.9. Flexicare Medical
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Key Financials
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Strategic Overview
  • 22.3.10. Hamilton Medical Inc.
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Key Financials
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Strategic Overview
  • 22.3.11. Intersurgical Inc
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Sales Footprint
    • 22.3.11.4. Key Financials
    • 22.3.11.5. SWOT Analysis
    • 22.3.11.6. Strategic Overview
  • 22.3.12. Inspired Medical
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Sales Footprint
    • 22.3.12.4. Key Financials
    • 22.3.12.5. SWOT Analysis
    • 22.3.12.6. Strategic Overview
  • 22.3.13. WILAMed GmBH
    • 22.3.13.1. Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Sales Footprint
    • 22.3.13.4. Key Financials
    • 22.3.13.5. SWOT Analysis
    • 22.3.13.6. Strategic Overview
  • 22.3.14. Besmed Health Business Corp
    • 22.3.14.1. Overview
    • 22.3.14.2. Product Portfolio
    • 22.3.14.3. Sales Footprint
    • 22.3.14.4. Key Financials
    • 22.3.14.5. SWOT Analysis
    • 22.3.14.6. Strategic Overview
  • 22.3.15. Shenzhen Micomme Medical Technology Development Co., Ltd
    • 22.3.15.1. Overview
    • 22.3.15.2. Product Portfolio
    • 22.3.15.3. Sales Footprint
    • 22.3.15.4. Key Financials
    • 22.3.15.5. SWOT Analysis
    • 22.3.15.6. Strategic Overview
  • 22.3.16. Shenyang RMS Medical Tech Co. Ltd.
    • 22.3.16.1. Overview
    • 22.3.16.2. Product Portfolio
    • 22.3.16.3. Sales Footprint
    • 22.3.16.4. Key Financials
    • 22.3.16.5. SWOT Analysis
    • 22.3.16.6. Strategic Overview
  • 22.3.17. BMC Medical Co., Ltd.
    • 22.3.17.1. Overview
    • 22.3.17.2. Product Portfolio
    • 22.3.17.3. Sales Footprint
    • 22.3.17.4. Key Financials
    • 22.3.17.5. SWOT Analysis
    • 22.3.17.6. Strategic Overview

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료